Phio Pharmaceuticals Corp. (PHIO)
1.15
-0.03
(-2.54%)
USD |
NASDAQ |
Aug 24, 16:00
1.15
0.00 (0.00%)
After-Hours: 20:00
Phio Pharmaceuticals Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.0045 |
| September 30, 2023 | 0.0097 |
| June 30, 2023 | 0.0105 |
| March 31, 2023 | 0.0189 |
| December 31, 2022 | 0.0157 |
| September 30, 2022 | 0.0149 |
| June 30, 2022 | 0.0138 |
| March 31, 2022 | 0.0136 |
| December 31, 2021 | 0.0135 |
| September 30, 2021 | 0.0124 |
| June 30, 2021 | 0.0123 |
| March 31, 2021 | 0.0122 |
| December 31, 2020 | 0.0493 |
| September 30, 2020 | 0.0433 |
| June 30, 2020 | 0.0392 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0411 |
| December 31, 2019 | 0.0901 |
| September 30, 2019 | 0.0713 |
| June 30, 2019 | 0.0584 |
| March 31, 2019 | 0.0508 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Imunon, Inc. | 1.873 |
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.31M |
| Total Liabilities (Quarterly) | 1.705M |
| Shareholders Equity (Quarterly) | 12.60M |
| Current Ratio | 8.386 |